Back to results
CompletedPhase 1Phase 2

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

NCT03058289

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

USC Norris

Los Angeles, California, United States

+7 additional locations

View on ClinicalTrials.gov
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 — TrialFind